Search

everythinglearnresearchcommunity

for

Search:↓

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Botanical treatments like saw palmetto, rosemary oil, and ginseng may help reduce hair loss in menopausal women.

Numerical methods help analyze alopecia drugs' properties effectively.

Nanofibers improve skincare products by enhancing drug delivery and hydration.

400 nm particles penetrate hair follicles best, but mouse models aren't fully reliable for human studies.

Emulgel improves skin delivery of various drugs better than traditional methods.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Upadacitinib may cause hair loss.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Injectable cryogels can deliver drugs and aid tissue repair with minimal surgery.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Advanced human skin models improve drug development and could replace animal testing.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

miR-140-5p in certain cell vesicles helps hair growth by boosting cell proliferation.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Ascorbic acid derivatives improve drug delivery systems.